Columbus Circle Investors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-7,294
Closed -$1.2M 247
2017
Q1
$1.2M Sell
7,294
-11,738
-62% -$1.95M 0.02% 241
2016
Q4
$2.78M Buy
+19,032
New +$2.86M 0.04% 210
2016
Q2
Sell
-72,789
Closed -$10.9M 254
2016
Q1
$10.9M Sell
72,789
-56,147
-44% -$8.34M 0.1% 172
2015
Q4
$20.9M Buy
128,936
+45,948
+55% +$7.22M 0.17% 134
2015
Q3
$11.5M Buy
82,988
+11,100
+15% +$1.75M 0.09% 180
2015
Q2
$11M Sell
71,888
-15,016
-17% -$2.41M 0.08% 212
2015
Q1
$13.9M Sell
86,904
-13,079
-13% -$2.06M 0.09% 187
2014
Q4
$15.9M Sell
99,983
-49,912
-33% -$7.78M 0.11% 164
2014
Q3
$21.1M Sell
149,895
-167,318
-53% -$21.8M 0.15% 136
2014
Q2
$37.5M Buy
+317,213
New +$36.7M 0.26% 101
2014
Q1
Sell
-183,627
Closed -$20.9M 282
2013
Q4
$20.9M Buy
183,627
+73,132
+66% +$8.32M 0.14% 153
2013
Q3
$12.4M Buy
110,495
+18,238
+20% +$1.98M 0.09% 215
2013
Q2
$9.1M Buy
+92,257
New +$9.57M 0.07% 210

Other funds holding AMGN

Columbus Circle Investors's AMGN Position: Q2 2017 in Review

Columbus Circle Investors sold out of Amgen (AMGN) in Q2 2017, closing a stake of 7,294 shares — an estimated $1.2M sold.

Columbus Circle Investors first reported a position in AMGN in Q2 2013 and held it in 13 quarters. The position peaked at $37.5M in Q2 2014. 1,595 funds tracked by Wall St. Rank hold AMGN as of Q2 2017.

  • Columbus Circle Investors reported no remaining Amgen position as of Q2 2017 after selling out during the quarter.
  • Columbus Circle Investors sold 7,294 Amgen shares in Q2 2017, an estimated $1.2M.
  • Columbus Circle Investors first reported a position in Amgen in Q2 2013 and held it in 13 quarters.
  • Columbus Circle Investors's Amgen position peaked at $37.5M in Q2 2014.
  • 1,595 funds tracked by Wall St. Rank held Amgen as of Q2 2017.

Based on Columbus Circle Investors's 13F filing for Q2 2017, filed 4 Aug 2017.